Role of Matrix Metalloproteinases in Invasion and Metastasis: Biology, Diagnosis and Inhibitors

Overview

Journal Cytotechnology

Specialties Biotechnology
Genetics

Date 1993 Jan 1

PMID 7764458

Citations 4

Authors

S McDonnell

B Fingleton

Affiliations

Soon will be listed here.

Abstract

The processes of tumour invasion and subsequent metastasis are the most lethal aspects of cancer. Whilst many factors are involved, the matrix metalloproteinases (MMPs) have been implicated as key-rate limiting enzymes in the invasive process. This family consisting of eight members of similar structure, can be roughly divided into three groups based on substrate specificity. All are secreted in a latent form and require proteolytic cleavage for activation. The expression of these enzymes is regulated at the transcriptional level by a variety of growth factors and oncogenes. They are also regulated at the protein level by a family of specific inhibitors called the tissue inhibitors of metalloproteinases (TIMPs). Studies in human tumour samples have shown a positive correlation between metalloproteinase expression and metastatic potential. The levels of metalloproteinase expression have been manipulated using molecular biology techniques in several cell lines and shown a similar correlation. These results suggest that an understanding of metalloproteinase expression and proteolytic activity may lead to the development of effective therapeutic agents with the potential to reduce the incidence of metastatic cancer.

Citing Articles

The most likely but largely ignored triggering factor for breast (or all) cancer invasion.

Man Y, Mannion C, Stojadinovic A, Peoples G, Cho W, Fu S J Cancer. 2023; 14(4):573-590.

PMID: 37057291 PMC: 10088539. DOI: 10.7150/jca.82291.

Quercetin downregulates matrix metalloproteinases 2 and 9 proteins expression in prostate cancer cells (PC-3).

Vijayababu M, Arunkumar A, Kanagaraj P, Venkataraman P, Krishnamoorthy G, Arunakaran J Mol Cell Biochem. 2006; 287(1-2):109-16.

PMID: 16645725 DOI: 10.1007/s11010-005-9085-3.

Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor.

Huang Y, Hwang J, Lee P, Ke F, Huang J, Huang C Br J Pharmacol. 1999; 128(5):999-1010.

PMID: 10556937 PMC: 1571723. DOI: 10.1038/sj.bjp.0702879.

Metastatic and non-metastatic colorectal cancer (CRC) cells induce host metalloproteinase production in vivo.

Mc Donnell S, Chaudhry V, Zeng Z, Shu W, Guillem J Clin Exp Metastasis. 1999; 17(4):341-9.

PMID: 10545021 DOI: 10.1023/a:1006651019335.

References

Hasty K, Pourmotabbed T, Goldberg G, Thompson J, Spinella D, Stevens R . Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases. J Biol Chem. 1990; 265(20):11421-4. View

Brenner D, Ohara M, Angel P, Chojkier M, Karin M . Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha. Nature. 1989; 337(6208):661-3. DOI: 10.1038/337661a0. View

Kolkenbrock H, Orgel D, NOACK W, Ulbrich N . The complex between a tissue inhibitor of metalloproteinases (TIMP-2) and 72-kDa progelatinase is a metalloproteinase inhibitor. Eur J Biochem. 1991; 198(3):775-81. DOI: 10.1111/j.1432-1033.1991.tb16080.x. View

Cohn K, Wang F, Solomon W, Patterson L, Arnold M, Weimar J . Association of nm23-H1 allelic deletions with distant metastases in colorectal carcinoma. Lancet. 1991; 338(8769):722-4. DOI: 10.1016/0140-6736(91)91444-y. View

Monteagudo C, Merino M, Liotta L, Stetler-Stevenson W . Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. Am J Pathol. 1990; 136(3):585-92. PMC: 1877499. View

McDonnell S, Kerr L, Matrisian L . Epidermal growth factor stimulation of stromelysin mRNA in rat fibroblasts requires induction of proto-oncogenes c-fos and c-jun and activation of protein kinase C. Mol Cell Biol. 1990; 10(8):4284-93. PMC: 360972. DOI: 10.1128/mcb.10.8.4284-4293.1990. View

McDonnell S, Matrisian L . Stromelysin in tumor progression and metastasis. Cancer Metastasis Rev. 1990; 9(4):305-19. DOI: 10.1007/BF00049521. View

Leone A, Flatow U, King C, Sandeen M, Margulies I, Liotta L . Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell. 1991; 65(1):25-35. DOI: 10.1016/0092-8674(91)90404-m. View

Goldberg G, Marmer B, Grant G, Eisen A, Wilhelm S, He C . Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc Natl Acad Sci U S A. 1989; 86(21):8207-11. PMC: 298249. DOI: 10.1073/pnas.86.21.8207. View

10.

Wilhelm S, Collier I, Kronberger A, Eisen A, Marmer B, Grant G . Human skin fibroblast stromelysin: structure, glycosylation, substrate specificity, and differential expression in normal and tumorigenic cells. Proc Natl Acad Sci U S A. 1987; 84(19):6725-9. PMC: 299156. DOI: 10.1073/pnas.84.19.6725. View

11.

Schultz R, Silberman S, Persky B, Bajkowski A, Carmichael D . Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res. 1988; 48(19):5539-45. View

12.

Muller D, Breathnach R, Engelmann A, Millon R, Bronner G, Flesch H . Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours. Int J Cancer. 1991; 48(4):550-6. DOI: 10.1002/ijc.2910480412. View

13.

Vogelstein B, Kinzler K . The multistep nature of cancer. Trends Genet. 1993; 9(4):138-41. DOI: 10.1016/0168-9525(93)90209-z. View

14.

Machida C, Rodland K, Matrisian L, Magun B, Ciment G . NGF induction of the gene encoding the protease transin accompanies neuronal differentiation in PC12 cells. Neuron. 1989; 2(6):1587-96. DOI: 10.1016/0896-6273(89)90047-0. View

15.

Powell W, KNOX J, Navre M, Grogan T, Kittelson J, Nagle R . Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice. Cancer Res. 1993; 53(2):417-22. View

16.

Wilhelm S, Collier I, Marmer B, Eisen A, Grant G, Goldberg G . SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem. 1989; 264(29):17213-21. View

17.

Stetler-Stevenson W, Krutzsch H, Liotta L . Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem. 1989; 264(29):17374-8. View

18.

Muller D, Quantin B, Gesnel M, Abecassis J, Breathnach R . The collagenase gene family in humans consists of at least four members. Biochem J. 1988; 253(1):187-92. PMC: 1149273. DOI: 10.1042/bj2530187. View

19.

Matrisian L, Bowden G, Krieg P, Furstenberger G, Briand J, Leroy P . The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumors. Proc Natl Acad Sci U S A. 1986; 83(24):9413-7. PMC: 387148. DOI: 10.1073/pnas.83.24.9413. View

20.

Wasylyk C, Gutman A, Nicholson R, Wasylyk B . The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins. EMBO J. 1991; 10(5):1127-34. PMC: 452766. DOI: 10.1002/j.1460-2075.1991.tb08053.x. View